We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+14.79%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.18B
AUM Growth
+$203M
Cap. Flow
-$31.5M
Cap. Flow %
-1.45%
Top 10 Hldgs %
35.11%
Holding
404
New
36
Increased
94
Reduced
108
Closed
38

Top Buys

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$32.8M
2
PFE icon
Pfizer
PFE
+$24.5M
3
AXP icon
American Express
AXP
+$24.2M
4
EPAM icon
EPAM Systems
EPAM
+$16.4M
5
MRK icon
Merck
MRK
+$16.1M

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$24.3M
2
EHC icon
Encompass Health
EHC
+$24M
3
USB icon
US Bancorp
USB
+$21.9M
4
EG icon
Everest Group
EG
+$18.7M
5
ETN icon
Eaton
ETN
+$17.7M

Sector Composition

Rank Sector Weight
1 Technology 33.85%
2 Healthcare 14.97%
3 Consumer Discretionary 12.67%
4 Financials 10.15%
5 Industrials 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBR icon
301
Petrobras
PBR
$118B
$10K ﹤0.01%
937
+150
+19% +$1.58K
PEP icon
302
PepsiCo
PEP
$188B
$10K ﹤0.01%
60
PG icon
303
Procter & Gamble
PG
$340B
$10K ﹤0.01%
59
PGR icon
304
Progressive
PGR
$124B
$10K ﹤0.01%
97
+8
+9% +$764
RMNI icon
305
Rimini Street
RMNI
$458M
$10K ﹤0.01%
1,740
T icon
306
AT&T
T
$165B
$10K ﹤0.01%
+530
New +$9.91K
TRV icon
307
Travelers Companies
TRV
$78.3B
$10K ﹤0.01%
60
VSH icon
308
Vishay Intertechnology
VSH
$5.08B
$10K ﹤0.01%
460
DDD icon
309
3D Systems Corp
DDD
$611M
$9K ﹤0.01%
420
FULC icon
310
Fulcrum Therapeutics
FULC
$286M
$9K ﹤0.01%
520
GILD icon
311
Gilead Sciences
GILD
$165B
$9K ﹤0.01%
+120
New +$8.27K
IVZ icon
312
Invesco
IVZ
$14B
$9K ﹤0.01%
406
-318
-44% -$7.74K
LMT icon
313
Lockheed Martin
LMT
$139B
$9K ﹤0.01%
25
-1
-4% -$346
MSCI icon
314
MSCI
MSCI
$40.9B
$9K ﹤0.01%
+15
New +$9.41K
OZK icon
315
Bank OZK
OZK
$5.63B
$9K ﹤0.01%
202
+16
+9% +$730
SO icon
316
Southern Company
SO
$105B
$9K ﹤0.01%
128
AVAV icon
317
AeroVironment
AVAV
$9.57B
$8K ﹤0.01%
130
DUK icon
318
Duke Energy
DUK
$94.5B
$8K ﹤0.01%
81
NTLA icon
319
Intellia Therapeutics
NTLA
$1.68B
$8K ﹤0.01%
70
PRU icon
320
Prudential Financial
PRU
$42.1B
$8K ﹤0.01%
72
MANT
321
DELISTED
Mantech International Corp
MANT
$8K ﹤0.01%
110
BHVN
322
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$8K ﹤0.01%
60
AMGN icon
323
Amgen
AMGN
$226B
$7K ﹤0.01%
30
ARWR icon
324
Arrowhead Research
ARWR
$12.5B
$7K ﹤0.01%
110
BPMC
325
DELISTED
Blueprint Medicines
BPMC
$7K ﹤0.01%
70

Similar funds

Smith Group Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Smith Group Asset Management held 404 positions worth $2.18B, up 10% from $1.97B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Smith Group Asset Management's Q4 2021 filing shows 36 new, 94 increased, 108 reduced and 38 closed positions. Its largest new stake was AutoNation: 130,907 shares worth $15.3M. The largest sale was PayPal, an estimated $24.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Smith Group Asset Management's largest Q4 2021 buy was AutoNation: 130,907 shares worth $15.3M.
  • Smith Group Asset Management added most to Zebra Technologies in Q4 2021, an estimated $32.8M increase.
  • Smith Group Asset Management's biggest Q4 2021 reduction was US Bancorp, cutting an estimated $21.9M.
  • Smith Group Asset Management fully exited PayPal in Q4 2021, selling an estimated $24.3M.
  • Smith Group Asset Management's ten largest holdings make up 35% of its $2.18B portfolio in Q4 2021.
  • Smith Group Asset Management opened 36 new positions and closed 38 in Q4 2021.
  • Smith Group Asset Management's portfolio value rose 10% quarter-over-quarter to $2.18B.

Based on Smith Group Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.